Sunniva (XCNQ:SNN) Cash Flow from Others : C$3.79 Mil (TTM As of Sep. 2019)

View and export this data going back to 2018. Start your Free Trial

What is Sunniva Cash Flow from Others?

Sunniva's cash flow from others for the three months ended in Sep. 2019 was C$1.02 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2019 was C$3.79 Mil.

Sunniva Cash Flow from Others Historical Data

The historical data trend for Sunniva's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva Cash Flow from Others Chart

Sunniva Annual Data

Trend

Dec16

Dec17

Dec18

Cash Flow from Others

0.84

5.44

-1.85

Sunniva Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Cash Flow from Others	Get a 7-Day Free Trial								-0.91	1.54	0.64	0.58	1.02

Sunniva Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was C$3.79 Mil.

Sunniva Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Sunniva's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunniva (XCNQ:SNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2

Website

https://www.sunniva.com

Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.

Executives

Mark Hamish Kimmins

Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)